Global Market Access: Essential Knowledge for Clinical Trial Design

DIA 2012 Collaborate to Innovate

48th Annual Meeting
June 24-28, 2012
Philadelphia, PA

Pennsylvania Convention Center

Global Market Access: Essential Knowledge for
Clinical Trial Design
June 24, 8:30AM - 12:00PM

Instructor(s):John Brennick, MPA
Worldwide Market Access
Janssen Global Services, LLC, United States

Description:
Reimbursement approvals from payers (reimbursers) have become as important as regulatory approvals for pharmaceutical product success and providing access to patients. Even with reimbursement approval, payer restrictions such as step edits and individual patient approval significantly impact product usage. This tutorial will provide an overview of global reimbursement systems including health technology assessments (e.g., NICE), and discuss ways in which evidence of value from clinical trials can help or limit market access.

Event	Credit Type	Max Credits	CEU
#23: Global Market Access: Essential Knowledge for	IACET	3.25	0.300

Learning Objectives:
At the conclusion of this tutorial, attendees should be able to:
• Summarize the evidence demands of global payer customers
• Discuss the growing importance of the reimbursement hurdle to patient access to your medicine
• Recognize how aspects of clinical trial design, such as dosing and comparator choice, can impact reimbursement potential

Target Audience:
This tutorial is designed for pharmaceutical industry employees not familiar with market access (pricing, reimbursement, health economics) issues.

for more information...